Esomeprazole Magnesium Capsule, Delayed Release
Product Images NDC 50090-7949

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 50090-7949). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
A line graph depicting the percentage maintained over a 6-month period for esomeprazole magnesium delayed-release capsules at doses of 40 mg, 20 mg, 10 mg, and placebo. The y-axis represents percent maintained, ranging from 0 to 110%, and the x-axis represents months from 0 to 6. Four lines show a trend with the 40 mg dose maintaining the highest percentage over time, followed by 20 mg, 10 mg, and placebo showing the lowest maintenance.*
FDA Label Image

Figure-3 (Figure 3)

Figure-3 (Figure 3)
A line graph showing the percent maintained over a 6-month period for Esomeprazole Magnesium delayed-release capsules at 40 mg and 20 mg strengths, 10 mg strength, and placebo. The x-axis represents months 0 to 6, and the y-axis represents percent maintained from 0 to 100%. Four lines depict the data for each group, indicating that higher strengths maintain a higher percentage over time compared to placebo.*
FDA Label Image

Figure-4 (Figure 4)

Figure-4 (Figure 4)
A line graph depicting the percent of patients symptom-free over a 28-day diary period. It compares Esomeprazole Magnesium Delayed-Release Capsules at 40 mg and 20 mg doses against a placebo group, showing symptom relief progression over time.*
FDA Label Image

Figure-5 (Figure 5)

Figure-5 (Figure 5)
A line chart comparing the percent of patients symptom-free over a 28-day diary period between Esomeprazole Magnesium delayed-release capsules at 40 mg and 20 mg doses and a placebo. The y-axis shows the percent of patients symptom-free, and the x-axis represents diary days from 0 to 28.*
FDA Label Image

Ink1 (Ink1)

Ink1 (Ink1)
Esomeprazole Magnesium 40 mg delayed-release capsules bottle label from A-S Medication Solutions. The label shows the proprietary name, strength, dosage form, and quantity information, indicating it is an oral prescription drug. The bottle has a white and red label with black text.*
FDA Label Image

Ink2 (Ink2)

Ink2 (Ink2)
Esomeprazole Magnesium 40 mg delayed-release capsules, in a blister pack of ten capsules. The capsules are light pink and white, each imprinted with the number '1053'. The packaging is labeled by A-S Medication Solutions.*
FDA Label Image

Label Image (Lbl500907949)

Label Image (Lbl500907949)
Label for Esomeprazole Magnesium delayed-release capsules, 40 mg, by A-S Medication Solutions. The label indicates the product NDC 50090-7949, storage instructions at 68 to 77 degrees Fahrenheit, and a quantity of 90 capsules. The label includes dosage directions reminder and lot identification.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of esomeprazole magnesium, showing the molecular components with two esomeprazole units complexed with magnesium and three water molecules (hydration).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.